pegaspargase Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Beijing Tongren Hospital (1)
Peking University (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadlymphoma

I am/have/hadt-cell lymphoma

I am/have/hadlymphoma, extranodal nk-t-cell

I am/have/hadremission

I am/have/hadextranodal nk/t-cell lymphoma, nasal type

I am/have/hadrenal function

I am/have/hadmyocardial infarction

I am/have/hadimmunohistochemistry

I am/have/hadacute myocardial infarction

I am/have/hadarrhythmia

I am/have/hadpet-ct scan

I am/have/hadPET-CT

I am/have/hadrenal function test

I am/have/hadrenal function tests

I am/have/hadpet/ct scan

added new label for I am/have/had

more

I am looking for

I am looking forpegaspargase

I am looking fordexamethasone

I am looking forgemcitabine

I am looking foretoposide

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For Seniors
Recruiting in 100s
Interventional Study
all
Recruiting

Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma

This phase II study aimed to evaluate the efficacy and safety of pegaspargase, cyclophosphamide, vincristine, etoposide and prednisone (COEPL) regimen combined with radiotherapy for patients with newly diagnosed ENKTL.

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

The purpose of this study is to evaluate the efficacy and safety of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in the treatment of Relapsed/Refractory or advanced NK/T-cell lymphoma patients (ENKTCL).

lymphoma

extranodal nk/t-cell lymphoma, nasal type

arrhythmia

gemcitabine

PET-CT

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.